Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
43 Cards in this Set
- Front
- Back
any unexpected, unintended, undesired or excessive response to a medication that leads to discontinuation of a drug, dose medication, necessitates use of supportive treatment, prolonged hospital stay, hospitalization, or leads to patient harm or death
|
adverse drug reactions
|
|
a response to a drug which is noxious and unintended and which occurs at doses normally used in man for prophylaxis, diagnosis or therapy of disease or modification of physiologic function
|
adverse drug reactions
|
|
a serious adverse event in which the patient outcome is death, life threatening, hospitalization, disability, congenital anomaly, or required intervention to prevent permanent impairment or damage
|
adverse drug reactions
|
|
an expected well known reaction resulting in little or no change in patient management
|
side effect
|
|
an example would be drowsiness or dry mouth resulting from certain antihistamines or nausea associated with the use of antineoplastic agents
|
side effect
|
|
T/F: Accidental poisoning, drug overdose complications are ADRs.
|
false
|
|
What percentage of the population experience adverse drug reactions?
|
10-20%
|
|
What percentage of hospitalized patients experience adverse drug reactions?
|
5-10%
|
|
Why is the percentage of hospitalized patients experiencing ADRs less than the population?
|
because the patients are being monitored
|
|
involves chart review to detect adverse drug reactions after patient has been treated and discharged from the hospital; patient has gone home and reports later
|
retrospective review
|
|
involves the detection and reporting of ADRs as soon as they occur; patient in hospital
|
prospective/concurrent review
|
|
Who is most likely to develop an adverse drug reaction?
|
patients on multiple medications
patients given medications they are allergic to patients with renal insufficiency elderly patients |
|
essential to avoid giving patients medications they are allergic to
|
documenting patient allergies
|
|
What occurs most often in patients who are on medication long-term and have not been dose adjusted?
|
adverse drug reactions
|
|
What ADR do antihistamines (Benadryl) treat?
|
hypersensitivity reactions
drug rashes |
|
What ADR does atropine treat?
|
bradycardia
|
|
What ADR does dexatrose 50% treat?
|
hypoglycemia
|
|
What ADR does naloxene treat?
|
narcotic antagonism
|
|
What ADR do steroids treat?
|
hypersensitivity reactions, drug rashes
|
|
What ADR does flumazenil treat?
|
Benzodiazepine antagonist
|
|
What ADR does Vitamin K treat?
|
Coumadin antagonist
|
|
What ADR does epinephrine treat?
|
hypersensitivity reaction
|
|
What ADR does calcium chloride treat?
|
calcium channel blocker overdose
|
|
What ADR does calcium gluconate treat?
|
calcium channel blocker overdose
|
|
What ADR do steriods (topical) treat?
|
hypersensitivity reaction
|
|
What ADR does dantrolene treat?
|
malignant hyperthemia, neuroleptic malignant syndrome
|
|
What ADR does digoxin immune fab (digibind) treat?
|
digoxin overdose
|
|
What ADR does sodium polystyrene sulfonate (Kayexelate) treat?
|
hyperkalemia
|
|
What do you do when an ADR occurs?
|
1. notify physician
2. monitor patient and provide supportive measures 3. document ADR on Medication Safety form and forward to pharmacy |
|
an ADR accurred that did not result in patient harm
|
Level I
|
|
an ADR occurred that resulted in the need for increased patient monitoring but no chane in vital signs and no patient harm
|
Level II
|
|
an ADR occurred that resulted in the need for increased patient monitoring with a change in vital signs or increased laboratory monitoring but no ultimate patient harm
|
Level III
|
|
an ADR occurred that resulted in the need for treatment with another drug or an increased length of stay (or that affected patient participation in an investigational drug study)
|
Level IV
|
|
an ADR occurred that resulted in permanent patient harm (initiate root cause analysis)
|
Level V
|
|
an ADR occurred that resulted in patient deat (initiate root cause analysis)
|
Level VI
|
|
Why report ADRs?
|
1. to meet regulatory agency guidelines
2. to prevent preventable ADRs 3. to implement process changes and formulary changes when applicable 4. to maintain and improve patient care |
|
What ADR should you watch for with insulin?
|
hypoglycemia
|
|
What ADR should you watch for with heparin?
|
bleeding
|
|
What ADR should you watch for with coumadin?
|
bleeding
|
|
What ADR should you watch for with lovenox?
|
bleeding
|
|
A patient who experienced rash and urticaria to sulfonamides in the past received sulfadiazine cream for wound care. An hour after cream was applied to the patient's legs, the patient experienced urticaria of the neck and arm. The cream was washed off and patient received diphenhydramine and hydrocortisone with relief of symptoms.
T/F: this patient had experienced an ADR reaction to sulfadiazine cream. |
true because you must give another drug to counteract it; allergy, not side effect
|
|
While reviewing the patient's chart, no trigger medications were identified from the physician's orders. However, laboratory values indicate an accucheck of 33. No documentation on progress notes regarding low glucose levels or changes in insulin orders. Nurses notes indicate patient being very shaky, lethargic, and slightly confused--accucheck was 33. Physician notified and dextrose 50$ half ampoule prescribed with accucheck follow-up. Later MD writes orders to change the sliding scale insulin.
T/F: you would consider this an ADR resulting from insulin. |
true because it is an undesired affect you must counteract
|
|
Patient is on Levaquin 500mmg IVPB for pneumonia. Physician discontinues IV Levaquin after 2 doses and orders Benadryl 25mg IV now, followed by 25mg PO Q6 hrs PRN itching. In progress notes, physician documents that patient developed a rash from Levaquin.
A. this patient has had an adverse drug reaction to Levaquin B. you would document this on an ADR/Med Safety Form and send to Pharm C. you'll call the FDA to report this reaction D. A & B E. A & C |
D
|